Trial Profile
A Randomized, Multicenter, Single-Masked, Parallel-Group Dose Finding Study Comparing the Safety and Efficacy of BOL-303259-X to Latanoprost in Subjects With Open Angle Glaucoma or Ocular Hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Jul 2018
Price :
$35
*
At a glance
- Drugs Latanoprostene bunod (Primary) ; Latanoprost
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- Acronyms VOYAGER
- Sponsors Bausch & Lomb
- 25 Jun 2014 New trial record